GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » 5-Year Share Buyback Ratio

Pacific Biosciences of California (STU:P09) 5-Year Share Buyback Ratio : -13.00% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Pacific Biosciences of California's current 5-Year Share Buyback Ratio was -13.00%.

STU:P09's 5-Year Share Buyback Ratio is ranked worse than
70.81% of 668 companies
in the Medical Devices & Instruments industry
Industry Median: -4.55 vs STU:P09: -13.00

Competitive Comparison of Pacific Biosciences of California's 5-Year Share Buyback Ratio

For the Medical Devices subindustry, Pacific Biosciences of California's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pacific Biosciences of California's 5-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's 5-Year Share Buyback Ratio falls into.


;
;

Pacific Biosciences of California 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Pacific Biosciences of California (STU:P09) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Pacific Biosciences of California 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Biosciences of California Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » 5-Year Share Buyback Ratio
Comparable Companies
CLPT SMLR CVRX SNWV TCMD NNOX ZIMV NPCE VMD LUNG ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
PACB:USA P09:Germany
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Website
https://www.pacb.com
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Pacific Biosciences of California Headlines

No Headlines